
PGinvIT – a worthy investment option?
Should you consider this InvIT built on power transmission assets?

Should you consider this InvIT built on power transmission assets?

SEBI’s new MF proposal could reshape your fund menu if written into law. Read about it here!

Understand why you must get a grip on terminal value to be a successful investor!

How diabetes drugs became weight loss blockbusters – and what it means for investors

Understand the current technical structure and what to expect in the near term.

Prime Funds is our list of recommendations in equity, debt, and hybrid mutual funds that are worth investing in. Prime Funds narrows down your choices from the

Results update for 7 of our Prime Stocks.

Making sense of the FY 25 numbers for this new-age company!

Results update for 9 of our Prime Stocks.

Results update for 12 of our Prime Stocks.

We had highlighted in the previous update on the Nifty 50 technical outlook that the index was vulnerable to a pull-back as the short-term trend

With Trump’s talk of tariffs dominating headlines, if you too have joined in the quest for stocks that may offer immunity from this threat then this vaccine-maker is one of our picks – Glaxosmithkline Pharmaceuticals Limited. This MNC pharma player has an enduring suite of brands that have withstood challenges, such as the advent of […]
Hold On
You are being redirected to another page,
Elevate Your Wealth with Professional Portfolio Management